Protalix BioTherapeutics
PLX
#8104
Rank
NZ$0.35 B
Marketcap
$4.57
Share price
0.39%
Change (1 day)
121.50%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): NZ$9.1 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$53.39 Million. a decrease over its 2023 earnings that were of NZ$20.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 NZ$9.16 M-55.62%
2023 NZ$20.64 M-199.05%
2022 -NZ$20.85 Million-40.38%
2021 -NZ$34.96 Million-732.31%
2020 NZ$5.52 M-130.53%
2019 -NZ$18.11 Million189.85%
2018 -NZ$6.25 Million-95.29%
2017 -NZ$0.14 Billion308.12%
2016 -NZ$32.52 Million-32.37%
2015 -NZ$48.08 Million10.11%
2014 -NZ$43.66 Million-7.59%
2013 -NZ$47.25 Million
2011 -NZ$54.71 Million-19.39%
2010 -NZ$67.87 Million20.87%
2009 -NZ$56.15 Million32.26%
2008 -NZ$42.46 Million-5.46%
2007 -NZ$44.91 Million
2004 -NZ$0.3 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.3 Million-57.03%
2001 -NZ$0.68 Million1.03%
2000 -NZ$0.68 Million-53.22%
1999 -NZ$1.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$50.51 Million-651.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B 9,740.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.51 B 212,955.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.5 Billion-5,506.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel